Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Sep 11, 2013 (13 years ago)

Risperdal CONSTA (Risperidone)

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Non-Sterility: Janssen is recalling one lot of Risperdal CONSTA (risperiDONE) due to a sterility failure in a stability sample

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Risperdal CONSTA (risperiDONE), 25 mg Dose Pack, Rx Only, Single Use Only Janssen Pharmaceuticals Inc., Titusville, NJ 08560 NDC 50458-306-11

Affected NDC 50458-0306-11

Compare with the code on your package — it is the most precise check available.

Drug: Risperidone

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Risperdal Consta
risperidone
NDC 50458-0306
Kit Janssen Pharmaceuticals, Inc. Rx
Recalling firm
Janssen Pharmaceuticals, Inc.
NDC code
50458-306-11
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1514-2014 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Risperidone recalls

See all
Class II · Moderate risk

RisperiDONE Oral Solution

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Terminated Microbial contamination Torrent Pharma Inc NDC 23155-317-51 D-1382-2019
Class II · Moderate risk

RisperiDONE Oral Solution

cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Terminated Microbial contamination Torrent Pharma Inc NDC 13668-589-06 D-1345-2019
Class III · Low risk

Risperidone Oral Solution

Failed Impurities/Degradation Specifications: Out of Specification for an impurity at the 18 month stability time point.

Terminated Impurity / degradation Apotex Inc. NDC 60505-0380-1 D-1299-2014

Other recalls by Janssen Pharmaceuticals, Inc.

All 2013 recalls
Class II · Moderate risk

Ortho-Novum 7/7/7

Labeling: Incorrect Instructions; Instructions included for use with the Veridate dispenser contained instructions for the Dialpak dispenser.

Terminated Labeling / mix-up Janssen Pharmaceuticals, Inc. NDC 50458-178-06 D-0218-2019
Class II · Moderate risk

Ortho-Novum 1/35

Labeling: Incorrect Instructions; Instructions included for use with the Veridate dispenser contained instructions for the Dialpak dispenser.

Terminated Labeling / mix-up Janssen Pharmaceuticals, Inc. NDC 50458-176-28 D-0217-2019